Skip to main content
. 2018 Feb 7;52(4):1178–1188. doi: 10.3892/ijo.2018.4268

Table I.

Clinical characteristics of patients in the TCGA and E-MTAB-4725 datasets.

Clinical characteristics TCGA (n=376) E-MTAB-4725 (n=204) P-value
Age (years; means ± SD) 57.64±5.44 55.73±12.97 0.1157a
Sex (male/female) 235/141 100/104 0.0023b
Pathologic_M (M0/M1/-) 351/19/6 202/2 0.0211b
Pathologic_N (N0/N1/N2/N3/-) 182/71/43/56/24 182/6/13/3 2.2E−16b
Pathologic_T (T1/T2/T3/T4/-) 62/73/80/128/33 6/66/72/59 1.72E−08b
Pathologic_stage (I/II/III/IV/-) 80/111/166/19 58/123/21/2 2.2E−16b
Radiation therapy (yes/no) 40/336
New tumor (yes/no) 220/153/3
Deceased (deceased/alive) 179/197 120/102 0.6192b
Overall survival (months; means ± SD) 58.33±56.59 73.57±40.16 0.0001a

Clinical characteristics between TCGA and E-MTAB-4725 were compared using the

a

Student's t-test or

b

Chi-square test. SD, standard deviation. The hyphen (−) indicates that data were unavailable. TCGA, The Cancer Genome Atlas.